Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study. Gynecol Oncol. 2021 05; 161(2):512-515.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Benzimidazoles
Bevacizumab
BRCA1 Protein
BRCA2 Protein
Carboplatin
Clinical Trials, Phase I as Topic
Female
Genes, BRCA1
Genes, BRCA2
Hematologic Diseases
Humans
Middle Aged
Multicenter Studies as Topic
Ovarian Neoplasms
Paclitaxel
Prospective Studies
authors with profiles
Joan L Walker